Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X Syndrome.

Saved in:
Bibliographic Details
Title: Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X Syndrome.
Authors: McKinney WS; Department of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Schmitt LM; Department of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., De Stefano LA; Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Ethridge L; Department of Psychology, University of Oklahoma, Norman, Oklahoma, USA.; Department of Pediatrics, Section of Developmental and Behavioral Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Norris JE; Department of Psychology, University of Oklahoma, Norman, Oklahoma, USA., Horn PS; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Dauterman S; Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Neuroscience Graduate Program, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Rosselot H; National Fragile X Foundation, Washington, DC, USA., Pedapati EV; Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Reisinger DL; Department of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Dominick KC; Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Shaffer RC; Department of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Chin D; The Heidt Center of Excellence, Cincinnati, Ohio, USA., Friedman NR; Department of Psychology, University of Alabama, Tuscaloosa, Alabama, USA., Hong M; Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Sweeney JA; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Erickson C; Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Source: Journal of child and adolescent psychopharmacology [J Child Adolesc Psychopharmacol] 2025 May; Vol. 35 (4), pp. 211-221. Date of Electronic Publication: 2024 Dec 09.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 9105358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8992 (Electronic) Linking ISSN: 10445463 NLM ISO Abbreviation: J Child Adolesc Psychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-8992
DOI:10.1089/cap.2024.0103